Complete the acquisition of Horizon Therapeutics plc
Delivered after the deadline (98 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 12 Dec 2022
- Due
- 30 Jun 2023
- Delivered
- 6 Oct 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“It is anticipated that the Scheme will, subject to obtaining the necessary regulatory approvals, be declared effective in the first half of 2023.”
What we found
Evidence strength A What the grades mean
Amgen announced an anticipated completion date in the first half of 2023, but the acquisition of Horizon Therapeutics was not finalized until October 6, 2023.
-
A Amgen Inc. 10-Q filed 2023-10-31
“On October 6, 2023, Amgen completed its acquisition of Horizon for $116.50 per share in cash” ✓ confirmed on the page
Market reaction: the shares moved -2.4% against the S&P 500 over the three sessions around the disclosure (30 Oct 2023 to 2 Nov 2023). What this measures
Checked 4 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Complete
- Deliverable
- Acquisition of Horizon Therapeutics plc
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: regulatory approvals; shareholder approval; court sanction
- Depends on
- Regulatory, Shareholder, Court
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Amgen Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-AMGN-004560 · Corrections policy